CoChat

Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 4 of the 12 sources its claims cite were checked for support.

Abstract

Common recommendations for cell line authentication, annotation and quality control fall short addressing genetic heterogeneity. Within the Human Toxome Project, we demonstrate that there can be marked cellular and phenotypic heterogeneity in a single batch of the human breast adenocarcinoma cell line MCF-7 obtained directly from a cell bank that are invisible with the usual cell authentication by short tandem repeat (STR) markers. STR profiling just fulfills the purpose of authentication testing, which is to detect significant cross-contamination and cell line misidentification. Heterogeneity needs to be examined using additional methods. This heterogeneity can have serious consequences for reproducibility of experiments as shown by morphology, estrogenic growth dose-response, whole genome gene expression and untargeted mass-spectroscopy metabolomics for MCF-7 cells. Using Comparative Genomic Hybridization (CGH), differences were traced back to genetic heterogeneity already in the cells from the original frozen vials from the same ATCC lot, however, STR markers did not differ from ATCC reference for any sample. These findings underscore the need for additional quality assurance in Good Cell Culture Practice and cell characterization, especially using other methods such as CGH to reveal possible genomic heterogeneity and genetic drifts within cell lines.

Overview

CoChat Summary

TL;DR

MCF-7 cells from the same ATCC lot and with matching STR profiles showed marked phenotypic, transcriptomic, metabolomic, and genomic heterogeneity between two laboratories. This heterogeneity was already present in DNA from original frozen vials and affected key functional outcomes such as estradiol-driven proliferation.

Key findings

  • Two laboratories (BU and JHU) using MCF-7 from the same ATCC lot (lot 59388743, passage 147) and identical STR profiles for all 9 typed markers observed different phenotypes: BU cells grew in large aggregations, while JHU cells grew flat with cobblestone morphology.
  • After 72 h exposure to estradiol, BU MCF-7 cells showed significant increases in proliferation at 0.1, 1, and 10 nM, whereas JHU cells showed no significant change; PPT exposure similarly increased proliferation in BU cells at 0.1, 1.0, and 10 nM but not in JHU cells.
  • Untargeted metabolomics PCA of 1048 features separated the two sublines and showed differential response to E2; microarray PCA showed transcriptional differences already in untreated control cells, and an 84-gene heat map clustered the sublines separately.
  • CGH detected almost the same significant genomic differences on chromosomes 1, 3, 4, 5, 7, 8, 9, 10, 13, 15, 20, and X in DNA directly prepared from two original never-thawed ATCC vials from the same lot as after a few passages in culture, while STR markers did not differ from the ATCC reference for any sample.

Methods

  • MCF-7 cells from the same ATCC lot were obtained by Brown University and Johns Hopkins University; one vial per lab was grown using identical protocols and Good Cell Culture Practice, with experiments performed at passage 3 (BU) and passage 8 (JHU), while a second vial per lab remained never thawed.
  • Assays included morphologic high-content imaging, estradiol/PPT proliferation and qRT-PCR for progesterone receptor, Agilent whole-genome gene expression microarrays, untargeted LC-MS metabolomics, Comparative Genomic Hybridization (CGH), and STR profiling.
  • Analyses included two-way ANOVA, principal component analysis, unsupervised hierarchical clustering, and CGH aberration detection with ADM-2 threshold 10; CGH and STR experiments were performed in one laboratory by one individual.

Limitations

  • The paper does not state a dedicated limitations section; it acknowledges that current authentication methods do not preclude genetic heterogeneity and that combining omics technologies does not overcome the limitations of tumor cell lines.
  • Evident from the text: the study compares only two laboratories and one ATCC lot of MCF-7, so the generalizability to other cell lines, lots, or laboratories is not directly tested, although the authors suggest MCF-7 is likely not unique.
  • Some verification experiments are reported only as “data not shown” (cells exchanged between laboratories), limiting independent assessment of those results.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/srep28994

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Morphological, phenotypical and gene expression differences of MCF-7 cells from the same ATCC batch (passsage number 154 JHU & passage number 150 BU). (A) MCF-7 sublines (JHU & BU) display distinct morphological differences. At 0 hours, BU MCF-7 cells and JHU cells have unique morphologies. MCF-7 cells grown and expanded at BU grow in large aggregations while JHU cells grown in the BU laboratory are flat, with cobblestone morphology. (B) Following 72 hours of exposure to estradiol (E2), BU MCF-7 cells displayed significant increases in proliferation (cell count) at concentrations of 0.1, 1 and 10 nM, while JHU cells did not have a significant change in cell count (left). Exposure to the estrogen receptor alpha agonist propyl pyrazole triol (PPT) for 72 hours resulted in a significant increase in proliferation at concentrations of 0.1, 1.0 and 10 nM in the BU subline, while JHU cells did not exhibit significant changes (right). (C) Gene expression analysis of the estrogen receptor target progesterone receptor (PgR) following 6 hours of exposure to E2 indicated that BU MCF-7 cells are responsive to low levels of estrogen. All experiments have been performed in one laboratory (BU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 1 Morphological, phenotypical and gene expression differences of MCF-7 cells from the same ATCC batch (passsage number 154 JHU & passage number 150 BU). (A) MCF-7 sublines (JHU & BU) display distinct morphological differences. At 0 hours, BU MCF-7 cells and JHU cells have unique morphologies. MCF-7 cells grown and expanded at BU grow in large aggregations while JHU cells grown in the BU laboratory are flat, with cobblestone morphology. (B) Following 72 hours of exposure to estradiol (E2), BU MCF-7 cells displayed significant increases in proliferation (cell count) at concentrations of 0.1, 1 and 10 nM, while JHU cells did not have a significant change in cell count (left). Exposure to the estrogen receptor alpha agonist propyl pyrazole triol (PPT) for 72 hours resulted in a significant increase in proliferation at concentrations of 0.1, 1.0 and 10 nM in the BU subline, while JHU cells did not exhibit significant changes (right). (C) Gene expression analysis of the estrogen receptor target progesterone receptor (PgR) following 6 hours of exposure to E2 indicated that BU MCF-7 cells are responsive to low levels of estrogen. All experiments have been performed in one laboratory (BU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Figure 2 Principal Component analysis (PCA) of MCF-7 cells LC-MS metabolomics data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 1 nM E2 for 4 hours or 24 hours either at Brown University (BU) or Johns Hopkins University (JHU). The data point colors in the graph represent samples from Brown University and at passage number 150 (BU, red) and Johns Hopkins University at passage number 154 (JHU, blue). The shapes represent the treatment time (square: 0 h, circle: 4 h and triangle: 24 h) while the size represents the experimental condition (small: controls and big: 1 nM E2 treatment). QC samples from each were also analyzed. They represent a pool of all samples in an individual experiment (diamond). A total of 1048 features were identified in the two experiments and were used for the multivariate analysis shown here.
Figure 2 Principal Component analysis (PCA) of MCF-7 cells LC-MS metabolomics data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 1 nM E2 for 4 hours or 24 hours either at Brown University (BU) or Johns Hopkins University (JHU). The data point colors in the graph represent samples from Brown University and at passage number 150 (BU, red) and Johns Hopkins University at passage number 154 (JHU, blue). The shapes represent the treatment time (square: 0 h, circle: 4 h and triangle: 24 h) while the size represents the experimental condition (small: controls and big: 1 nM E2 treatment). QC samples from each were also analyzed. They represent a pool of all samples in an individual experiment (diamond). A total of 1048 features were identified in the two experiments and were used for the multivariate analysis shown here.CC BY · PubMed Central
Figure 3 Principal Component analysis (PCA) of MCF-7 cells Gene Expression microarray data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 5 nM propyl pyrazole triol (PPT) for 4 hours or 8 hours (cell culture details see Materials and Methods) either at Brown University (BU) at passage number 150 or Johns Hopkins University (JHU) at passage number 154. The colors in the graph represent samples from Brown University (BU, red) and Johns Hopkins University (JHU, blue). The shapes represent the treatment time (circle: 4 h and triangle: 8 h) while the size represents the experimental condition (small: 0 nM controls and big: 5 nM PPT treatment). A total of 29,787 entities representing detected probes were used for the multivariate analysis shown here.
Figure 3 Principal Component analysis (PCA) of MCF-7 cells Gene Expression microarray data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 5 nM propyl pyrazole triol (PPT) for 4 hours or 8 hours (cell culture details see Materials and Methods) either at Brown University (BU) at passage number 150 or Johns Hopkins University (JHU) at passage number 154. The colors in the graph represent samples from Brown University (BU, red) and Johns Hopkins University (JHU, blue). The shapes represent the treatment time (circle: 4 h and triangle: 8 h) while the size represents the experimental condition (small: 0 nM controls and big: 5 nM PPT treatment). A total of 29,787 entities representing detected probes were used for the multivariate analysis shown here.CC BY · PubMed Central
Figure 4 Unsupervised hierarchical clustering of MCF-7 cells Gene Expression microarray data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 5 nM propyl pyrazole triol (PPT) for 4 or 8 hours (cell culture details see Materials and Methods) either at Brown University (BU) at passage number 150 or Johns Hopkins University (JHU) at passage number 154. 84 genes covering estrogen receptor signaling, breast and ductal morphogenesis, cellular growth and differentiation, proliferation, tumor progression and epithelial to mesenchymal transition have been selected from the literature17. Cluster algorithm used Euclidean distances and Wards linkage criteria on entities and conditions of probes encoding genes. Gene Symbols in bottom labeling columns (often multiple probes represent each gene on microarray). Label plots on the right show conditions corresponding to PPT dose (nM), Time Point (hours) and Institution (Johns Hopkins University, JHU; Brown University, BU), respectively. Color range represents data baselined to the median and log 2 transformed. Comparing two sample from 0 (yellow) to +2 (red) or −2 (blue) would be 4 fold change.
Figure 4 Unsupervised hierarchical clustering of MCF-7 cells Gene Expression microarray data from the same ATCC batch. MCF-7 cells were treated with 0 nM or 5 nM propyl pyrazole triol (PPT) for 4 or 8 hours (cell culture details see Materials and Methods) either at Brown University (BU) at passage number 150 or Johns Hopkins University (JHU) at passage number 154. 84 genes covering estrogen receptor signaling, breast and ductal morphogenesis, cellular growth and differentiation, proliferation, tumor progression and epithelial to mesenchymal transition have been selected from the literature17. Cluster algorithm used Euclidean distances and Wards linkage criteria on entities and conditions of probes encoding genes. Gene Symbols in bottom labeling columns (often multiple probes represent each gene on microarray). Label plots on the right show conditions corresponding to PPT dose (nM), Time Point (hours) and Institution (Johns Hopkins University, JHU; Brown University, BU), respectively. Color range represents data baselined to the median and log 2 transformed. Comparing two sample from 0 (yellow) to +2 (red) or −2 (blue) would be 4 fold change.CC BY · PubMed Central
Figure 5 Reproducibility of CGH for two technical replicates of MCF-7 cells. Comparative Genomic Hybridization of two technical replicates of MCF-7 cells from ATCC lot number 59388743 from Johns Hopkins University at passage number 154 (JHU P154, (A) darkblue and darkcyan), and Brown University and at passage number 150 (BU P150, (B) darkolivegreen and darksalmon) versus human female reference DNA. Within (A,B) respectively, only very minor differences can be seen showing very good reproducibility of CGH. Significant genomic differences detected by the Aberration Detection Method 2 (ADM-2) are indicated by the respective horizontal lines at −2 and +2, respectively. All experiments have been performed in one laboratory (JHU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility.
Figure 5 Reproducibility of CGH for two technical replicates of MCF-7 cells. Comparative Genomic Hybridization of two technical replicates of MCF-7 cells from ATCC lot number 59388743 from Johns Hopkins University at passage number 154 (JHU P154, (A) darkblue and darkcyan), and Brown University and at passage number 150 (BU P150, (B) darkolivegreen and darksalmon) versus human female reference DNA. Within (A,B) respectively, only very minor differences can be seen showing very good reproducibility of CGH. Significant genomic differences detected by the Aberration Detection Method 2 (ADM-2) are indicated by the respective horizontal lines at −2 and +2, respectively. All experiments have been performed in one laboratory (JHU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility.CC BY · PubMed Central
Figure 6 Direct CGH of MCF-7 genomics DNA from two original ATCC vials of the same batch and after short culture. Direct Comparative Genomic Hybridization (CGH) of MCF-7 genomic DNA derived from ATCC lot number 59388743, passage 147. Genomic DNA has been directly prepared from two original ATCC vials with the same lot number but shipped at two different time points to two different laboratories (blue) and after few passages in cell culture in the related laboratories (green; JHU passage number 154, BU passage number 150). For the comparative analysis the JHU samples have been defined as reference samples. Both CGH show significant genomic differences on chromosomes 1, 3, 4, 5, 7, 8, 9, 10, 13, 15, 20 and X as detected by the Aberration Detection Method 2 (ADM-2), which are very similar in both comparisons and are indicated by the respective horizontal lines at −1 and +1, respectively. Note, that to show the smaller differences between the different MCF-7 samples in comparison to MCF-7 versus normal female genome (Fig. 5), the Y-axis has been changed. All experiments have been performed in one laboratory (JHU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility.
Figure 6 Direct CGH of MCF-7 genomics DNA from two original ATCC vials of the same batch and after short culture. Direct Comparative Genomic Hybridization (CGH) of MCF-7 genomic DNA derived from ATCC lot number 59388743, passage 147. Genomic DNA has been directly prepared from two original ATCC vials with the same lot number but shipped at two different time points to two different laboratories (blue) and after few passages in cell culture in the related laboratories (green; JHU passage number 154, BU passage number 150). For the comparative analysis the JHU samples have been defined as reference samples. Both CGH show significant genomic differences on chromosomes 1, 3, 4, 5, 7, 8, 9, 10, 13, 15, 20 and X as detected by the Aberration Detection Method 2 (ADM-2), which are very similar in both comparisons and are indicated by the respective horizontal lines at −1 and +1, respectively. Note, that to show the smaller differences between the different MCF-7 samples in comparison to MCF-7 versus normal female genome (Fig. 5), the Y-axis has been changed. All experiments have been performed in one laboratory (JHU) by one individual to exclude any possible inter-laboratory and/or inter-operator effects on reproducibility.CC BY · PubMed Central
Figure 7
Figure 7 CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 2 Not checked · 31 Own results and interpretations

7 more claims

Create a free account to see all 38 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 114

Metadata

Authors
Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., Maertens, A., Rosenberg, M., Yager, J. D., Zhao, L., & Hartung, T.
Affiliations
  • Brown University (US)
  • Johns Hopkins University (US)
  • The Hamner Institutes for Health Sciences (US)
  • Georgetown University (US)
  • Agilent Technologies (United States) (US)
Venue
Scientific Reports
Published
2016-07-26
Volume
6
Issue
1
Pages
28994-28994
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2493132014
Cited by
114
References
28
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 14 · 2020: 11 · 2019: 16 · 2018: 26 · 2017: 15 · 2016: 3
FWCI
7.68
Type
journal article
Language
en
Update notices
erratum (2016-09-14)
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KOPS (University of Konstanz) (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute of Environmental Health Sciences (R01ES020750)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
MCF-7 cells, cell line authentication, genetic heterogeneity, short tandem repeat profiling, comparative genomic hybridization, genomic heterogeneity, genetic drift, gene expression profiling, metabolomics, reproducibility
MeSH terms
Genetic Markers, Humans, Genetic Variation, Reproducibility of Results, Microsatellite Repeats, Gene Expression Profiling, Cell Line, Tumor, Comparative Genomic Hybridization, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.